|
Market Closed -
Nasdaq
04:00:00 2026-10-19 pm EDT
|
5-day change | 1st Jan Change | ||
| 153.07 USD | -2.00% |
|
+1.75% | +24.71% |
| 06:43am | Gilead's pill succeeds in mid-stage bowel disease trial | RE |
| Oct. 16 | Gilead Sciences Insider Sold Shares Worth $468,660, According to a Recent SEC Filing | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.05% | +2.99% | +2.90% | +16.31% | +26.23% | +25.85% | +97.51% | +131.58% | +111.25% | 194B | |
| -0.39% | +5.79% | +7.40% | +9.08% | +16.41% | +54.65% | +111.76% | +416.31% | +1,492.52% | 1,120B | |
| -0.54% | -3.58% | -5.64% | +2.19% | +22.87% | +31.26% | +66.94% | +55.17% | +121.90% | 616B | |
| -0.31% | +1.24% | +7.61% | +12.32% | +24.56% | +22.64% | +95.57% | +164.87% | +363.29% | 504B | |
| +0.24% | +5.58% | +4.19% | +14.59% | +15.81% | +35.22% | +59.40% | +6.19% | +62.57% | 367B | |
| -1.12% | -0.60% | -3.29% | +16.22% | +37.35% | +67.49% | +43.96% | +81.88% | +133.68% | 360B | |
| -0.40% | +3.53% | +6.94% | +0.89% | +13.32% | +19.26% | +46.55% | +61.95% | +65.82% | 288B | |
| -0.37% | +3.11% | -1.27% | +0.16% | -10.08% | -1.31% | +18.23% | +41.89% | +150.99% | 258B | |
| -1.03% | +2.60% | +8.97% | +17.64% | +30.89% | +41.24% | +52.68% | +107.19% | +165.97% | 234B | |
| -1.19% | +0.04% | -1.35% | -21.80% | -21.14% | -28.71% | -62.51% | -23.43% | +85.67% | 173B | |
| -0.29% | +3.75% | +6.22% | +19.05% | +18.33% | +19.34% | -5.53% | -30.00% | -9.62% | 169B | |
| +0.99% | -0.36% | -1.09% | +5.13% | +11.42% | +20.53% | +38.47% | +172.45% | +517.32% | 127B | |
| -1.03% | +2.66% | -5.61% | -1.75% | +9.58% | +35.60% | +4.66% | +2.64% | +18.53% | 122B | |
| +0.12% | +5.26% | +13.48% | +20.99% | +22.64% | +27.70% | +121.94% | +396.57% | +524.39% | 117B | |
| -0.40% | +4.74% | -2.93% | -1.43% | +1.67% | +13.56% | +27.83% | +5.46% | -10.87% | 99.56B | |
| -1.29% | -0.82% | -4.80% | -7.67% | -14.16% | -17.98% | -28.13% | -14.06% | +3.63% | 96.96B | |
| +4.14% | +6.62% | +31.77% | +283.07% | +672.76% | +736.59% | +176.66% | -31.69% | - | 87.04B | |
| -0.51% | +3.36% | -1.22% | +17.30% | +2.15% | +36.70% | -2.50% | +42.81% | +114.04% | 78.96B | |
| +0.03% | +4.11% | +8.86% | +6.97% | +17.74% | +27.80% | -3.80% | -25.99% | +46.12% | 70.58B | |
| -0.30% | +5.23% | -6.11% | -13.53% | -23.16% | -7.95% | +35.89% | +61.50% | +430.04% | 66.2B | |
| Average | -0.26% | +3.11% | +3.25% | +19.79% | +43.76% | +57.97% | +44.78% | +81.16% | +230.91% | 257.37B | |
| Weighted average by Cap. | -0.41% | +3.35% | +3.31% | +12.35% | +27.12% | +43.82% | +63.51% | +146.88% | +454.97% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
